A study led by researchers at the School of Medicine suggests a procedure called hip resurfacing may be a better option than total hip replacement for some patients, particularly those who are young and active.
A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots. The multicenter study, led by researchers at Washington University School of Medicine in St. Louis, will evaluate customized warfarin dosage based on patient genetics and will test which range of blood clotting is optimal in orthopedic patients.
Surgeons cut and reposition hip bones to reduce pain.When an older person has a hip problem, surgeons often replace the damaged hip with an artificial one. But that’s not a good option for someone in their 20s or 30s, so orthopaedic surgeons at the School of Medicine are repairing damage to the hip to prevent arthritis without having to replace the hip joint.